WHO urges action against HIV drug resistance threat

The World Health Organization (WHO) HIV drug resistance report 2017 shows that of the 36.7 million people living with HIV worldwide, 19.5 million people were accessing anti-retroviral therapy in 2016. The majority of these people are doing well, with treatment proving highly effective in suppressing the HIV virus. But a growing number are experiencing the consequences of drug resistance. In 6 of the 11 countries surveyed in Africa, Asia and Latin America, over 10% of people starting antiretroviral therapy had a strain of HIV that was resistant to some of the most widely used HIV medicines.

The Organization warns that this growing threat could undermine global progress in treating and preventing HIV infection if early and effective action is not taken.